Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1Other hematologic neoplasm 1

Conditions

Lymphoma 549Precursor Cell Lymphoblastic Leukemia-Lymphoma 511Lymphoma, Non-Hodgkin 437Lymphoma, Follicular 405Lymphoma, Large B-Cell, Diffuse 392Leukemia, Lymphocytic, Chronic, B-Cell 392Lymphoma, B-Cell 248Lymphoma, Mantle-Cell 224Hodgkin Disease 209Recurrence 205Leukemia, Myeloid, Acute 199Leukemia 196Multiple Myeloma 185Burkitt Lymphoma 185Lymphoma, B-Cell, Marginal Zone 170Neoplasms 153Myelodysplastic Syndromes 134Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 86Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 83Lymphoma, T-Cell 82Lymphoma, T-Cell, Cutaneous 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 63Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 55Breast Neoplasms 55Leukemia, B-Cell 52Myeloproliferative Disorders 50Lymphoproliferative Disorders 47

Interventions

varlilumab 1Vincristine 1Tomography, X-Ray Computed 1Rituximab 1Prednisone 1Nivolumab 1Interferons 1Immunoglobulin G 1Etoposide 1Echocardiography 1EPOCH protocol 1Doxorubicin 1Disulfides 1Cyclophosphamide 1Caves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphomatoid Granulomatosis × Lymphoid × 1 year × Clear all
NCT03038672 2026-05-12

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting
54 enrolled 12 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphomatoid Granulomatosis, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Primary Effusion

NCT01676805 2026-05-05

Tissue Collection for Studies of Lymph Cancer

National Institutes of Health Clinical Center (CC)

Recruiting
1,295 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Multiple Myeloma, Leukemia-Lymphoma, Adult T-Cell

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡